Catapult Capital Management’s Medtronic MDT Stock Holding History

Catapult Capital Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-65,000	Closed	-$5.07M	–	265
2015 Q1	$5.07M	Sell	65,000 -78,934	-55%	-$5.98M	0.62%	47
2014 Q4	$10.4M	Buy	+143,934	New	+$10M	2.64%	6
2014 Q2	–	Sell	-43,969	Closed	-$2.71M	–	229
2014 Q1	$2.71M	Buy	+43,969	New	+$2.56M	0.54%	58

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Catapult Capital Management's MDT Position: Q2 2015 in Review

Catapult Capital Management sold out of Medtronic (MDT) in Q2 2015, closing a stake of 65,000 shares — an estimated $5.07M sold.

Catapult Capital Management first reported a position in MDT in Q1 2014 and held it in 3 quarters. The position peaked at $10.4M in Q4 2014. 1,260 funds tracked by Wall St. Rank hold MDT as of Q2 2015.

Catapult Capital Management reported no remaining Medtronic position as of Q2 2015 after selling out during the quarter.
Catapult Capital Management sold 65,000 Medtronic shares in Q2 2015, an estimated $5.07M.
Catapult Capital Management first reported a position in Medtronic in Q1 2014 and held it in 3 quarters.
Catapult Capital Management's Medtronic position peaked at $10.4M in Q4 2014.
1,260 funds tracked by Wall St. Rank held Medtronic as of Q2 2015.

Based on Catapult Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.